Jim, sorry for the delay. Below is some information. I have more recent information, however, I just gave it out to someone to read. When I get it back I'll sent it to you. It is from a new book that hasn't been released to the public yet. I have an advanced copy. Best od Health, NI.
REFERENCE: HEPATITIS B and C RESEARCH TREATMENT OF CHRONIC HEPATITIS USING WHEY PROTEIN (NON HEATED) A. Watanabe, K. Higuchi, K. Okada, Y. Shimizu, Y. Kondo*, and H. Kohri*, Third Department of Internal Medicine, Toyama Medical and Pharmaceutical University. Toyama, Japan, and *Otsuka Pharmaceutical Factory, Inc., Nutrition Research Institute, Tokushima, Japan In an open study, the clinical efficacy of whey protein (Immunocal: cysteine content; 7.6-fold that of casein) isolated from fresh milk and purified without being heated was evaluated based on liver function test, immunological parameters, plasma or lymphocyte GSH concentrations and hepatitis virus markers in 25 patients with chronic hepatitis B or C. Immunocal (12g as protein) food (mousse) was given twice a day, in the morning and evening, for 12 weeks (test period). Casein (12g as protein) food (mousse) was given for 2 weeks prior to the start of supplement with Immunocal food (induction period) and for 4 weeks after the end (follow-up period). The effects of Immunocal food on various clinical parameters were examined at week intervals for 18 weeks to evaluate the efficacy of Immunocal. As a result, serum ALT activity decreased in 6 of 8 patients with chronic hepatitis B 12 weeks after the start of supplement with Immunocal food. Plasma GSH concentrations were increased in 5 of the 8 patients. Serum concentrations of lipid peroxides significantly decreased 8 weeks after Immunocal food. Serum IL-2 levels began to increase 8 weeks and remained high even after supplement with Immunocal food had ended. Furthermore, NK activity was significantly increased. However, an item correlating with reduced serum ALT activity could not be clarified. In 17 patients with chronic hepatitis C, there were no significant Immunocal-related changes in liver function test or Immunocal parameters. These findings suggest that long-term supplement with Immunocal alone may be effective for patients with chronic hepatitis B, and a further clinical study that long-term combination therapy with Immunocal and other agents including interferon may be effective for those with chronic hepatitis C should be performed. For further information please call (209) 474-7488. Ask for Ni Orsi or Jack Cope. NOTE: Abstracts, studies and clinical trials to follow. If for any reason these educational documents are not of interest, please call and we will remove you from our mailing/fax list. Ni Orsi wrote: > -----Original Message----- > From: [email protected] <[email protected]> > To: [email protected] <[email protected]> > Date: Monday, December 28, 1998 7:42 AM > Subject: [Fwd: Fwd: CS>***Help Hep C] > > >hi ni > > > >i have hep C (for twenty years now) and am very interested in a message > >that you posted in the silver-list. > > > >first things first.... > > > >1. what does "NAC" mean? > > > >2. what is "NAC theraypy"? > > > >i'd appreciate some direction on this matter :) > > > >take good care, > > > >jim pelletier > > > > ------------------------------------------------------------------------ > > Subject: Fwd: CS>***Help Hep C > Date: Sun, 27 Dec 1998 18:03:17 EST > From: [email protected] > To: [email protected] > > > > ------------------------------------------------------------------------ > > Subject: Re: CS>***Help Hep C > Resent-Date: Wed, 16 Dec 1998 17:53:43 -0800 > Resent-From: [email protected] > Date: Wed, 16 Dec 1998 17:53:36 -0800 > From: Ni Orsi <[email protected]> > To: [email protected] > References: <[email protected]> <[email protected]> > <[email protected]> > > Debbie, in a new book recently released called: The Ultimate GSH > Handbook, by Jimmy Gutman, MD, FACEP page 25: "In chronic infections > such as hepatitis C or AIDS, GSH (glutathione) depletion is even more > pronounced. Recent research has demonstrated that elevated GSH levels > address these infections more effectively." then on page 75: "GSH in the > treatment of viral hepatitis - Weiss and his team at the Max Planck > Institute demonstrated the anti viral properties on NAC in human tissue > cultures. Watanbe found that Immunocal, a natural GSH precursor, to be > effective in improving liver function abnormalities and immunological > parameters in hepatitis B patients. These improvements continued even > after the treatment ended, reflecting the long-term benefits of such an > approach. Treatment options for chronic hepatitis C sufferers are far > from ideal. Barbaro et al eloquently described the systemic depletion of > GSH in hepatitis C patients, suggesting that this deficiency could > explain their resistance to interferon therapy. Beloqui's team confirms > this in a controlled study of hepatitis C positive individuals. By > successfully raising one group's GSH levels with NAC therapy, they > showed that interferon therapy was enhanced." > Immunocal is a natural way for the body to increase GSH levels, proven > by 20+ years of research including Phase I, II & III trials and is > covered in some cases by insurance. If anyone wants additional > information, please e-mail or call (877) 687-2277 toll free. Best of > Health, Ni. > > -- > The silver-list is a moderated forum for discussion of colloidal silver. > > To join or quit silver-list or silver-digest send an e-mail message to: > [email protected] -or- [email protected] > with the word subscribe or unsubscribe in the SUBJECT line. > > To post, address your message to: [email protected] > > List maintainer: Mike Devour <[email protected]> -- The silver-list is a moderated forum for discussion of colloidal silver. To join or quit silver-list or silver-digest send an e-mail message to: [email protected] -or- [email protected] with the word subscribe or unsubscribe in the SUBJECT line. To post, address your message to: [email protected] List maintainer: Mike Devour <[email protected]>
